Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonyl Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111548341B offers a novel route for lenalidomide key intermediate. Enhanced yield and scalability for pharmaceutical supply chains.
Patent CN101570492B details a high-yield ephedrine synthesis route reducing solvent use and environmental impact for scalable pharmaceutical manufacturing supply chains.
Patent CN113443950A details a metal-free illumination method for reducing carbonyl to methylene, offering significant cost reduction in fine chemical manufacturing and greener synthesis routes.
Patent CN111944855B details a high-yield enzymatic route for (R)-1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethanol, offering superior stereoselectivity.
Patent CN113549102B reveals a thiourea-free ozone/CO method for removing p-methoxyphenyl groups, offering high purity and reduced sulfur waste for API manufacturing.
Patent CN109182410B details a high-yield biocatalytic route for chiral piperidine intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN112708641A discloses a high-efficiency chemo-enzymatic route for tomoxetine. Achieves >99.9% ee and high substrate loading for cost-effective manufacturing.
Novel preparation method using NaBH4/CeCl3 achieves over 90% yield for high-purity fragrance and pharmaceutical intermediates, offering significant cost and time advantages over traditional epoxidation routes.
Patent CN1295209C details a green selenium-catalyzed reduction of azo compounds using CO. This method offers high purity pharmaceutical intermediates with significant cost and safety advantages.
Discover a novel preparation method for Levalbuterol Hydrochloride via asymmetric reduction. Achieve high purity without column chromatography for cost-effective API manufacturing.